Top Story

Edwards temporarily halts transcatheter mitral valve replacement clinical program

May 23, 2015

Edwards Lifesciences announced that it has implemented a temporary pause in enrollment in its Fortis clinical program for development of a transcatheter mitral valve replacement system.

“We observed evidence of valve thrombosis that we believe warrants additional investigation,” the company stated in a press release. “We are working closely with the trial investigators and heart teams to gather additional information in this early study of transcatheter mitral valve replacement therapy.”

Michael R. Zile, MD Meeting News CoveragePerspective

Baroreflex activation therapy may benefit HF patients without CRT

May 22, 2015
BOSTON — For patients with HF who underwent baroreflex activation therapy, the magnitude of effect was greater in those without a chronic resynchronization therapy…
Meeting News Coverage

Atrial septal closure device explant may resolve nickel allergy symptoms

May 22, 2015
SAN DIEGO — Patients with nickel allergy and severe refractory symptoms after implantation with an atrial septal closure device experienced complete resolution of…

Evolocumab recommended for approval in Europe

May 22, 2015
Amgen announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion for the marketing authorization…
Arnold Greenspon, MD In the Journals

Repeat revisions for ICDs, CRT-Ds linked to substantial costs

May 22, 2015
When a patient with an implantable cardioverter defibrillator or a cardiac resynchronization therapy defibrillator undergoes more than one revision procedure…
More News Headlines »

Case Study: Elderly Woman with Type 2 Diabetes Mellitus and Acute Coronary Syndrome

This activity is supported by an educational grant from Daiichi Sankyo, Inc. and Lilly USA, LLC

Managing patients with acute coronary syndrome (ACS), as well as choosing the most appropriate antiplatelet therapy and…
More »
Meeting News Coverage Video
VIDEO: Community awaits PCSK9 inhibitor phase 3 results, approval

VIDEO: Community awaits PCSK9 inhibitor phase 3 results, approval

May 17, 2015
SAN DIEGO — C. Noel Bairey Merz, MD, FACC, director of the Barbra Streisand Women’s Heart Center in the…
More »
Cardiology Case Consults

The Patient With Statin Intolerance

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with statin intolerance.
More »